logo

For the Inventor, By the Inventor

Seattle, WA, United States of America

Linda M Gustavson

This inventor holds 32 USPTO granted patents and 1 published patent application and 1 EPO patent, primarily in Radiopharmaceutical Chemistry. Top assignees: Neorx Corporation, Neurogen Corporation, Aletheon Pharmaceuticals, Inc.. Active years: 1992-2010.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Linda M Gustavson. Retrieved from https://idiyas.com/inventor/linda-m-gustavson

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 32 

% Patents Active = 75.0


Average Co-Inventor Count = 4.0

ph-index = 13

Forward Citations = 430(Granted Patents)


Location History:

  • Seattle, WA (US) (1992 - 2004)
  • Guildford, CT (US) (2006)
  • Ringoes, NJ (US) (2007)
  • Guilford, CT (US) (2003 - 2010)

Company Filing History:

goldMedal20 out of 156 
 
Neorx Corporation
 patents
silverMedal10 out of 305 
 
Neurogen Corporation
 patents
bronzeMedal1 out of 3 
 
Aletheon Pharmaceuticals, Inc.
 patents
4. 1 out of 834,513 
Other
 patents

Years Active: 1992-2010

Loading Chart...
Loading Chart...
Areas of Expertise:
Benzimidazole Derivatives
Pyridylimidazole Derivatives
Melanin Concentrating Hormone
GABAA Receptor Ligands
Pretargeting Methods
Radionuclide Chelates
Biotin Conjugates
Polymeric Carriers
Radiolabeled Proteins
Therapeutic Use
Diagnostic Applications
Small Molecules
32 patents (USPTO):Explore Patents
1. 7642267 - Benzimidazole and pyridylimidazole derivatives (2010-01-05),
2. 7300945 - Benzimidazole and pyridylimidazole derivatives (2007-11-27),
3. 7253168 - Substituted 1-benzyl-4-substituted piperazine analogues (2007-08-07),
4. 7241765 - Melanin concentrating hormone receptor ligands: substituted 1-benzyl-4-aryl piperazine analogues (2007-07-10),
5. 7160879 - Melanin concentrating hormone receptor ligands: substituted 2-(4-benzyl-piperazin-1-ylmethyl)- and 2-(4-benzyl-diazepan-1-ylmethyl)-1H-benzoimidazole analogues (2007-01-09),
6. 7078013 - Pretargeting methods and compounds (2006-07-18),
7. 7030144 - Substituted imidazole derivatives: GABAA receptor ligands (2006-04-18),
8. 6953801 - Melanin concentrating hormone receptor ligands: substituted 1-benzyl-4-aryl piperazine analogues (2005-10-11),
9. 6916819 - Benzimidazole and pyridylimidazole derivatives (2005-07-12),
10. 6906075 - Melanin concentrating hormone receptor ligands: substituted benzoimidazole analogues (2005-06-14),
11. 6709652 - Pretargeting methods and compounds (2004-03-23),
12. 6656941 - Aryl substituted tetrahydroindazoles (2003-12-02),
13. 6358490 - Three-step pretargeting methods and compounds (2002-03-19),
14. 6287536 - Two-step pretargeting methods using improved bidtin-active agent conjugates (2001-09-11),
15. 6022966 - Pretargeting methods and compounds (2000-02-08),

Certainly! Here is the article about the inventor Linda M Gustavson:

Title: Inspiring Innovation: The Legacy of Linda M Gustavson

Introduction:

Innovation knows no bounds when it comes to Linda M Gustavson, a trailblazing inventor based in Seattle, WA. With a remarkable portfolio of 32 patents to her name, Linda's passion for innovation and unwavering commitment to excellence continue to shape the landscape of technology and inspire the next generation of inventors worldwide.

Latest Patents:

Linda's latest groundbreaking invention revolves around Benzimidazole and Pyridylimidazole derivatives. These compounds, characterized by Formula I, exhibit high selectivity and affinity for the benzodiazepine site of GABA receptors. The pharmaceutical compositions comprising these compounds show promise in treating various central nervous system (CNS) diseases. Furthermore, Linda's novel processes for preparing these compounds open new avenues for potentiating the effects of other CNS agents and serve as essential probes for localizing GABA receptors in tissue sections.

Career Highlights:

Throughout her illustrious career, Linda M Gustavson has made significant contributions to the field of biotechnology and pharmacology. She has lent her expertise to renowned companies such as Neorx Corporation and Neurogen Corporation, where her innovative spirit and dedication to pushing boundaries have left an indelible mark.

Collaborations:

In her journey towards innovation, Linda has collaborated with esteemed professionals in the industry. Notable among them are her coworkers John M Reno and Louis J Theodore. Together, they have spearheaded research projects, exchanged ideas, and propelled each other towards achieving groundbreaking discoveries in the realm of biomedicine.

Conclusion:

As we look towards the future of technology and the ever-evolving landscape of inventions, Linda M Gustavson stands as a beacon of inspiration and a testament to the power of relentless innovation. Her pioneering work continues to redefine possibilities, setting the stage for a future where boundaries are meant to be transcended, and innovations are meant to shape a better world for all.

If you need more information or have any specific requests, feel free to let me know!

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…